We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
AUM
$2.71B
AUM Growth
-$470M
Cap. Flow
-$273M
Cap. Flow %
-10.06%
Top 10 Hldgs %
34.36%
Holding
423
New
90
Increased
142
Reduced
147
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 23.88%
2 Healthcare 10.34%
3 Financials 10.01%
4 Consumer Discretionary 8.79%
5 Industrials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBRA icon
251
Zebra Technologies
ZBRA
$17.8B
$1.6M 0.06%
4,144
-314
-7% -$122K
GSK icon
252
GSK
GSK
$106B
$1.54M 0.06%
45,514
+7,078
+18% +$255K
DKS icon
253
Dick's Sporting Goods
DKS
$18.7B
$1.53M 0.06%
6,702
+1,381
+26% +$290K
Z icon
254
Zillow
Z
$7.56B
$1.53M 0.06%
20,700
-8,333
-29% -$596K
ET icon
255
Energy Transfer Partners
ET
$69.3B
$1.53M 0.06%
77,933
SBUX icon
256
Starbucks
SBUX
$120B
$1.52M 0.06%
+16,684
New +$1.61M
VKTX icon
257
Viking Therapeutics
VKTX
$4B
$1.51M 0.06%
37,575
-10,179
-21% -$580K
O icon
258
Realty Income
O
$59.1B
$1.5M 0.06%
28,166
-101,835
-78% -$5.93M
IEMG icon
259
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$1.5M 0.06%
28,705
+13,672
+91% +$757K
VNQ icon
260
Vanguard Real Estate ETF
VNQ
$39B
$1.49M 0.06%
16,759
-20,939
-56% -$1.98M
KMB icon
261
Kimberly-Clark
KMB
$36.5B
$1.47M 0.05%
11,182
+593
+6% +$80.8K
MO icon
262
Altria Group
MO
$114B
$1.45M 0.05%
27,691
+4,421
+19% +$236K
AZN icon
263
AstraZeneca
AZN
$250B
$1.45M 0.05%
11,041
+2,308
+26% +$323K
BRK.B icon
264
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.44M 0.05%
3,184
+123
+4% +$56.8K
IGSB icon
265
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$1.41M 0.05%
+27,211
New +$1.41M
EVRG icon
266
Evergy
EVRG
$19.2B
$1.4M 0.05%
+22,700
New +$1.4M
DOW icon
267
Dow Inc
DOW
$21.2B
$1.38M 0.05%
34,435
+1,136
+3% +$53K
BRK.A icon
268
Berkshire Hathaway Class A
BRK.A
$1.12T
$1.36M 0.05%
2
TKR icon
269
Timken Company
TKR
$9.03B
$1.28M 0.05%
17,961
+3,502
+24% +$275K
CVS icon
270
CVS Health
CVS
$122B
$1.28M 0.05%
28,542
+3,062
+12% +$172K
AKRO
271
DELISTED
Akero Therapeutics
AKRO
$1.27M 0.05%
+45,778
New +$1.39M
F icon
272
Ford
F
$55.7B
$1.24M 0.05%
125,568
+21,288
+20% +$227K
CCI icon
273
Crown Castle
CCI
$32.2B
$1.22M 0.05%
13,472
+2,152
+19% +$225K
TILT icon
274
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.26B
$1.2M 0.04%
+5,560
New +$1.22M
ACAD icon
275
Acadia Pharmaceuticals
ACAD
$5.03B
$1.19M 0.04%
+64,660
New +$1.04M

Similar funds

F/M Investments's Q4 2024 Portfolio in Review

As of Q4 2024, F/M Investments held 423 positions worth $2.71B, down 15% from $3.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

F/M Investments withdrew a net $273M in Q4 2024, closing 24 positions and reducing 147 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $8.88M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in RadNet worth $3.8M.

  • F/M Investments's largest Q4 2024 buy was RadNet: 54,342 shares worth $3.8M.
  • F/M Investments added most to F/M 2-Year Investment Grade Corporate Bond ETF in Q4 2024, an estimated $140M increase.
  • F/M Investments's biggest Q4 2024 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $21.1M.
  • F/M Investments fully exited iShares Russell 2000 ETF in Q4 2024, selling an estimated $8.88M.
  • F/M Investments's ten largest holdings make up 34% of its $2.71B portfolio in Q4 2024.
  • F/M Investments opened 90 new positions and closed 24 in Q4 2024.
  • F/M Investments's portfolio value fell 15% quarter-over-quarter to $2.71B.

Based on F/M Investments's 13F filing for Q4 2024, filed 13 Feb 2025.